The conference sub-site was funded by the Ministry of Education and Science (Project: “Excellent Science – Support for scientific conferences”) under the project entitled: “Implementation of two editions of the online scientific conference “Miopia” in 2023 and 2024″ contract No. DNK/SN/549820/2022)

Funding value: 217,982.15  PLN

Total value of the project: 257,834.15 PLN

The purpose of the Project is the preparation and implementation by the Foundation for Supporting the Development of Ophthalmology “Ophthalmology 21” of two editions of the scientific conference “Miopia” and dissemination of their results. The project will be implemented for 24 months from 01.11.2022 to 31.10.2024.

“Miopia 2024: Innovations” – program

June 7, 2024

12.30 – 12.35 PM CEST

OPEN prof. Andrzej Grzybowski

12.35 –12:55


The future of Myopia control – the questions that should be answered – Mark A. Bullimore

12:55 – 13:10


New technologies in Myopia Control I

1:10 – 1:30 CEST

Essilor Stellest lenses: latest clinical evidence. Dr Renan Ferreira Oliveira, Head of Medical Affairs EssilorLuxottica (Brazil)

1:30 – 1:50 CEST

European experience with RLRL. Prof. A. Grzybowski, University of Warmia and Mazury, (Poland)

1:50 – 2:10 CEST

Atropine in Myopia control. Prof. Carla Lanca, Escola Superior de Tecnologia da Saúde de Lisboa (ESTeSL), Instituto Politécnico de Lisboa, Lisboa, Portugal, Comprehensive Health Research Center (CHRC), Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisboa, (Portugal)

2:10 – 2:30 CEST

Protocol for introducing combined therapy for myopia control using optical and pharmacological methods. Dr Przeździecka-Dołyk, Wroclaw Medical University (Poland)

2:30 – 2:45 CEST


2:45 – 3:00 CEST – 14.15


SESSION II – New technologies in Myopia Control II

3:00 – 3:20 CEST

Combination therapy in the control of myopia – results of 2-year follow-up in the Polish population. Dr n. med. Joanna Przeździecka-Dołyk, Wroclaw Medical University (Poland)

3:20 – 3:40 CEST

The Strategy of Myopia Intervention Affect the Prevalence of Reduced Visual Acuity Schoolchildren in Taiwan. Prof. Pei-Chang Wu, Taiwan (director of Myopia Treatment and Prevention Center (Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital), professor at Chang Gung University, supervisor of the Ophthalmological Society of Taiwan (Chinese Taipei)

3:40 – 4:00 CEST

Contact lenses in Myopia. Dr. Imran Jawaid, Nottingham University Hospitals, NHS Trust (UK)

4:00 – 4:15 CEST


SESSION III – New technologies in Myopia Management

4:15 – 4:35 CEST

Myopia management guideline supported by Myopia Navigator David Kern (UK)

4:35 – 4:55 CEST

How do I diagnose and monitor myopia control? Prof. Hakan Kaymak (Germany)

4:55 – 5:15 CEST

AI in Myopia detection and control: Update 2024. Prof. Mohammad Hassan Emamian, Shahroud University of Medical Sciences, Shahroud, (Iran)

5:15 – 5:35 CEST

What changes occur in the optic nerve head of myopic axial elongation in children? Prof. KI HO Park (Department of Ophthalmology Seoul National University Hospital, Seoul National University College of Medicine)

5:35 – 5:50 CEST


5:50 – 5:55 CEST

End of the conference – prof. A. Grzybowski

Font Resize